当前位置： SCI文献检索 > PHARMACOLOGY & THERAPEUTICS期刊下所有文献 > Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.

Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function.

Abstract：

:The purpose of this paper is to provide an integrative review and offer novel insights regarding human research with classic psychedelics (classic hallucinogens), which are serotonin 2A receptor (5-HT2AR) agonists such as lysergic acid diethylamide (LSD), mescaline, and psilocybin. Classic psychedelics have been administered as sacraments since ancient times. They were of prominent interest within psychiatry and neuroscience in the 1950s to 1960s, and during this time contributed to the emergence of the field of molecular neuroscience. Promising results were reported for treatment of both end-of-life psychological distress and addiction, and classic psychedelics served as tools for studying the neurobiological bases of psychological disorders. Moreover, classic psychedelics were shown to occasion mystical experiences, which are subjective experiences reported throughout different cultures and religions involving a strong sense of unity, among other characteristics. However, the recreational use of classic psychedelics and their association with the counterculture prompted an end to human research with classic psychedelics in the early 1970s. We provide the most comprehensive review of epidemiological studies of classic psychedelics to date. Notable among these are a number of studies that have suggested the possibility that nonmedical naturalistic (non-laboratory) use of classic psychedelics is associated with positive mental health and prosocial outcomes, although it is clear that some individuals are harmed by classic psychedelics in non-supervised settings. We then review recent therapeutic studies suggesting efficacy in treating psychological distress associated with life-threatening diseases, treating depression, and treating nicotine and alcohol addictions. We also describe the construct of mystical experience, and provide a comprehensive review of modern studies investigating classic psychedelic-occasioned mystical experiences and their consequences. These studies have shown classic psychedelics to fairly reliably occasion mystical experiences. Moreover, classic-psychedelic-occasioned mystical experiences are associated with improved psychological outcomes in both healthy volunteer and patient populations. Finally, we review neuroimaging studies that suggest neurobiological mechanisms of classic psychedelics. These studies have also broadened our understanding of the brain, the serotonin system, and the neurobiological basis of consciousness. Overall, these various lines of research suggest that classic psychedelics might hold strong potential as therapeutics, and as tools for experimentally investigating mystical experiences and behavioral-brain function more generally.

journal_name

Pharmacol Ther

journal_title

Pharmacology & therapeutics

authors

Johnson MW,Hendricks PS,Barrett FS,Griffiths RR

doi

10.1016/j.pharmthera.2018.11.010

subject

Has Abstract

pub_date

2019-05-01 00:00:00

pages

83-102

eissn

0163-7258

issn

1879-016X

pii

S0163-7258(18)30215-8

journal_volume

197

pub_type

杂志文章,评审

相关文献

PHARMACOLOGY & THERAPEUTICS文献大全
  • From consensus sequence to high-affinity ligands: acquisition of signaling protein modulators.

    abstract：:Protein kinases recognize and bind to specific amino acid sequences on their protein substrates. These sequences can be readily identified using combinatorial peptide libraries. Unfortunately, conventional peptide libraries are not designed to identify subtle structural factors that can dramatically enhance enzyme aff...

    journal_title：Pharmacology & therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/s0163-7258(02)00187-0

    authors： Yeh RH,Lee TR,Lawrence DS

    更新日期：2002-02-01 00:00:00

  • Ryanodine receptor-mediated arrhythmias and sudden cardiac death.

    abstract：:The cardiac ryanodine receptor-Ca2+ release channel (RyR2) is an essential sarcoplasmic reticulum (SR) transmembrane protein that plays a central role in excitation-contraction coupling (ECC) in cardiomyocytes. Aberrant spontaneous, diastolic Ca2+ leak from the SR due to dysfunctional RyR2 contributes to the formation...

    journal_title：Pharmacology & therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/j.pharmthera.2009.03.006

    authors： Blayney LM,Lai FA

    更新日期：2009-08-01 00:00:00

  • Biological effects of inhibitors of S-adenosylhomocysteine hydrolase.

    abstract：:S-Adenosylhomocysteine (AdoHcy), formed after the donation of the methyl group of S-adenosylmethionine to a methyl acceptor, is hydrolyzed to adenosine and homocysteine by AdoHcy hydrolase physiologically. The administration of the inhibitors of AdoHcy hydrolase to cells or animals normally results in an accumulation ...

    journal_title：Pharmacology & therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/s0163-7258(97)00089-2

    authors： Chiang PK

    更新日期：1998-02-01 00:00:00

  • Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application.

    abstract：:Major depression is a debilitating and recurrent disorder with a substantial lifetime risk and a high social cost. Depressed patients generally display co-morbid symptoms, and depression frequently accompanies other serious disorders. Currently available drugs display limited efficacy and a pronounced delay to onset o...

    journal_title：Pharmacology & therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/j.pharmthera.2005.11.006

    authors： Millan MJ

    更新日期：2006-05-01 00:00:00

  • Synaptic plasticity and phosphorylation.

    abstract：:A number of neuronal functions, including synaptic plasticity, depend on proper regulation of synaptic proteins, many of which can be rapidly regulated by phosphorylation. Neuronal activity controls the function of these synaptic proteins by exquisitely regulating the balance of various protein kinase and protein phos...

    journal_title：Pharmacology & therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/j.pharmthera.2006.06.003

    authors： Lee HK

    更新日期：2006-12-01 00:00:00

  • Measurement of sister chromatid exchanges and their relationship to DNA damage, repair and cell killing.

    abstract：:We have concentrated on how SCE is measured, how it correlates with other measures of cellular damage, and how SCE can be used as a tool to study cell cycle kinetics. We have not discussed the biological significance of SCEs, i.e. why they occur spontaneously, and what role, if any, in cellular preservation they play....

    journal_title：Pharmacology & therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/0163-7258(89)90030-2

    authors： Deen DF,Morgan WF,Tofilon PJ,Barcellos-Hoff MH

    更新日期：1989-01-01 00:00:00

  • Induced differentiation, the cell cycle, and the treatment of cancer.

    abstract：:Hybrid polar compounds, of which hexamethylene bisacetamide (HMBA) is the prototype, have been shown to be potent inducers of differentiation of many types of transformed cells. With virus-transformed murine erythroleukemia cells as a model, HMBA was shown to cause these cells to arrest in G1 phase and express globin ...

    journal_title：Pharmacology & therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/0163-7258(95)02044-6

    authors： Rifkind RA,Richon VM,Marks PA

    更新日期：1996-01-01 00:00:00

  • Leukotrienes and inflammation.

    abstract：:The leukotrienes are synthesized from essential fatty acids via a 5-lipoxygenase enzyme. Most is known about the four-series leukotrienes derived from arachidonic acid. Leukotriene B4 is a potent chemotactic agent for leukocytes and it induces neutrophil-dependent increased microvascular permeability. Leukotrienes C4,...

    journal_title：Pharmacology & therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/0163-7258(90)90035-z

    authors： Brain SD,Williams TJ

    更新日期：1990-01-01 00:00:00

  • Benzodiazepines, anxiety and immunity.

    abstract：:Experimental and clinical studies suggest that the central and peripheral benzodiazepine (BDZ) receptors together with their ligands form the molecular basis of a novel regulatory network that contributes to the effects of anxiety on immune status. The peripheral-type receptors located on phagocytes and glial cells ap...

    journal_title：Pharmacology & therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/s0163-7258(97)00055-7

    authors： Zavala F

    更新日期：1997-09-01 00:00:00

  • Overcoming drug resistance to receptor tyrosine kinase inhibitors: Learning from lung cancer.

    abstract：:There are various receptor tyrosine kinase (TK)-targeted drugs that are currently used in the treatment of patients with non-small cell lung cancer (NSCLC). Among them, the epidermal growth factor receptor (EGFR) TK inhibitors (TKIs) are the most extensively studied. Receptor TKIs including EGFR TKIs have shown dramat...

    journal_title：Pharmacology & therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/j.pharmthera.2016.03.002

    authors： Kuwano M,Sonoda K,Murakami Y,Watari K,Ono M

    更新日期：2016-05-01 00:00:00

  • Molecular mechanism of retroviral DNA integration.

    abstract：:The integration of retroviral DNA appears to be obligatory for the efficient replication of retroviruses in their respective host cells. During a natural infection, integration takes place in a process that includes biochemically and temporally discrete steps. These are: (1) the removal of two nucleotides from the 3' ...

    journal_title：Pharmacology & therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/0163-7258(94)90062-0

    authors： Kulkosky J,Skalka AM

    更新日期：1994-01-01 00:00:00

  • Vascular Disrupting Agents in cancer treatment: Cardiovascular toxicity and implications for co-administration with other cancer chemotherapeutics.

    abstract：:Destruction of the established tumour vasculature by a class of compound termed Vascular Disrupting Agents (VDAs) is showing considerable promise as a viable approach for the management of solid tumours. VDAs induce a rapid shutdown and collapse of tumour blood vessels, leading to ischaemia and consequent necrosis of ...

    journal_title：Pharmacology & therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/j.pharmthera.2019.06.001

    authors： Gill JH,Rockley KL,De Santis C,Mohamed AK

    更新日期：2019-10-01 00:00:00

  • The pharmacological exploitation of cholesterol 7alpha-hydroxylase, the key enzyme in bile acid synthesis: from binding resins to chromatin remodelling to reduce plasma cholesterol.

    abstract：:Mammals dispose of cholesterol mainly through 7alpha-hydroxylated bile acids, and the enzyme catalyzing the 7alpha-hydroxylation, cholesterol 7alpha-hydroxylase (CYP7A1), has a deep impact on cholesterol homeostasis. In this review, we present the study of regulation of CYP7A1 as a good exemplification of the extraord...

    journal_title：Pharmacology & therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/j.pharmthera.2007.08.003

    authors： Gilardi F,Mitro N,Godio C,Scotti E,Caruso D,Crestani M,De Fabiani E

    更新日期：2007-12-01 00:00:00

  • Bronchial epithelium as a target for innovative treatments in asthma.

    abstract：:Increasing evidence of a critical role played by the bronchial epithelium in airway homeostasis is opening new therapeutic avenues. Its unique situation at the interface with the environment suggests that the subtle regulation orchestrated by the epithelium between tolerance and specific immune response might be impai...

    journal_title：Pharmacology & therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/j.pharmthera.2013.07.008

    authors： Gras D,Chanez P,Vachier I,Petit A,Bourdin A

    更新日期：2013-12-01 00:00:00

  • Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients.

    abstract：:The widespread coronavirus SARS-CoV-2 has already infected over 4 million people worldwide, with a death toll over 280,000. Current treatment of COVID-19 patients relies mainly on antiviral drugs lopinavir/ritonavir, arbidol, and remdesivir, the anti-malarial drugs hydroxychloroquine and chloroquine, and traditional C...

    journal_title：Pharmacology & therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/j.pharmthera.2020.107587

    authors： Liu T,Luo S,Libby P,Shi GP

    更新日期：2020-09-01 00:00:00

  • Dopamine D2 autoreceptor interactome: Targeting the receptor complex as a strategy for treatment of substance use disorder.

    abstract：:Dopamine D2 autoreceptors (D2ARs), located in somatodendritic and axon terminal compartments of dopamine (DA) neurons, function to provide a negative feedback regulatory control on DA neuron firing, DA synthesis, reuptake and release. Dysregulation of D2AR-mediated DA signaling is implicated in vulnerability to substa...

    journal_title：Pharmacology & therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/j.pharmthera.2020.107583

    authors： Chen R,Ferris MJ,Wang S

    更新日期：2020-09-01 00:00:00

  • New hope for cancer treatment: exploring the distinction between normal adult stem cells and cancer stem cells.

    abstract：:For decades, intensive studies have attempted to identify the mechanisms underlying malignant tumor growth. Despite significant progress, most therapeutic approaches fail to eliminate all tumor cells. The remaining tumor cells often result in recurrence and metastasis. Recently, the idea of a cancer stem cell was prop...

    journal_title：Pharmacology & therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/j.pharmthera.2008.04.008

    authors： Zhao RC,Zhu YS,Shi Y

    更新日期：2008-07-01 00:00:00

  • G-protein-coupled receptor dimerization: modulation of receptor function.

    abstract：:G-protein-coupled receptors (GPCRs) comprise the largest family of transmembrane receptors in the human genome that respond to a plethora of signals, including neurotransmitters, peptide hormones, and odorants, to name a few. They couple to second messenger signaling cascade mechanisms via heterotrimeric G-proteins. R...

    journal_title：Pharmacology & therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/s0163-7258(01)00160-7

    authors： Rios CD,Jordan BA,Gomes I,Devi LA

    更新日期：2001-11-01 00:00:00

  • Pericytes for the treatment of orthopedic conditions.

    abstract：:Pericytes and other perivascular stem cells are of growing interest in orthopedics and tissue engineering. Long regarded as simple regulators of angiogenesis and blood pressure, pericytes are now recognized to have MSC (mesenchymal stem cell) characteristics, including multipotentiality, self-renewal, immunoregulatory...

    journal_title：Pharmacology & therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/j.pharmthera.2016.08.003

    authors： James AW,Hindle P,Murray IR,West CC,Tawonsawatruk T,Shen J,Asatrian G,Zhang X,Nguyen V,Simpson AH,Ting K,Péault B,Soo C

    更新日期：2017-03-01 00:00:00

  • The sigma-1 receptor as a regulator of dopamine neurotransmission: A potential therapeutic target for methamphetamine addiction.

    abstract：:Methamphetamine (METH) abuse is a major public health issue around the world, yet there are currently no effective pharmacotherapies for the treatment of METH addiction. METH is a potent psychostimulant that increases extracellular dopamine levels by targeting the dopamine transporter (DAT) and alters neuronal activit...

    journal_title：Pharmacology & therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/j.pharmthera.2018.01.009

    authors： Sambo DO,Lebowitz JJ,Khoshbouei H

    更新日期：2018-06-01 00:00:00

  • Serotonin receptors involved in antidepressant effects.

    abstract：:The neurotransmitter serotonin (5-hdroxytryptamine; 5-HT) has been implicated in the pathophysiology and treatment of major depression since the serendipitous discovery of antidepressant drugs in the 1950s. However, despite the generalised use of serotonin-enhancing drugs, such as the selective serotonin reuptake inhi...

    journal_title：Pharmacology & therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/j.pharmthera.2012.09.006

    authors： Artigas F

    更新日期：2013-01-01 00:00:00

  • Novel therapeutics for type 2 diabetes: incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors.

    abstract：:Known treatments of type 2 diabetes mellitus have limitations such as weight gain, and hypoglycaemias. A new perspective is the use of incretin hormones and incretin enhancers. Incretins are defined as being responsible for the higher insulin release after an oral glucose load compared to an intravenous glucose load. ...

    journal_title：Pharmacology & therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/j.pharmthera.2009.06.002

    authors： Verspohl EJ

    更新日期：2009-10-01 00:00:00

  • Lung development, regeneration and plasticity: From disease physiopathology to drug design using induced pluripotent stem cells.

    abstract：:Lungs have a complex structure composed of different cell types that form approximately 17 million airway branches of gas-delivering bronchioles connected to 500 million gas-exchanging alveoli. Airways and alveoli are lined by epithelial cells that display a low rate of turnover at steady-state, but can regenerate the...

    journal_title：Pharmacology & therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/j.pharmthera.2017.10.002

    authors： Ahmed E,Sansac C,Assou S,Gras D,Petit A,Vachier I,Chanez P,De Vos J,Bourdin A

    更新日期：2018-03-01 00:00:00

  • Mechanisms of monooxygenase induction and inhibition.

    abstract：:The mechanisms of monooxygenase induction and inhibition have been discussed from the standpoint of historic development, from the current concepts about the molecular mechanism of enzyme induction, and from the various possibilities by which inhibitors can interact with the complex cytochrome P-450 monooxygenase syst...

    journal_title：Pharmacology & therapeutics

    pub_type： 历史文章,杂志文章,评审

    doi：10.1016/0163-7258(87)90020-9

    authors： Netter KJ

    更新日期：1987-01-01 00:00:00

  • Targeting oncogenic drivers in lung cancer: Recent progress, current challenges and future opportunities.

    abstract：:Targeted therapies have changed the landscape of treatments for non-small cell lung cancer (NSCLC). Specific targeted therapies have been approved for NSCLC patients harboring genetic alterations in four oncogenes, and agents targeting additional oncogenic drivers are under investigation. Standard first-line chemother...

    journal_title：Pharmacology & therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/j.pharmthera.2018.08.007

    authors： Yoda S,Dagogo-Jack I,Hata AN

    更新日期：2019-01-01 00:00:00

  • Immunotherapy in sepsis - brake or accelerate?

    abstract：:Sepsis, a life threating syndrome characterized by organ failure after infection, is the most common cause of death in hospitalized patients. The treatment of sepsis is generally supportive in nature, involving the administration of intravenous fluids, vasoactive substances and oxygen plus antibiotics to eliminate the...

    journal_title：Pharmacology & therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/j.pharmthera.2020.107476

    authors： Steinhagen F,Schmidt SV,Schewe JC,Peukert K,Klinman DM,Bode C

    更新日期：2020-04-01 00:00:00

  • Protein kinase inhibitors and antibiotic resistance.

    abstract：:While antibiotics revolutionized the treatment of infectious disease in the 20th century, bacterial resistance now threatens to render many of them ineffective. Aminoglycosides are a class of clinically important antibiotics used in the treatment of infections caused by Gram-positive and -negative organisms. They are ...

    journal_title：Pharmacology & therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/s0163-7258(02)00197-3

    authors： Burk DL,Berghuis AM

    更新日期：2002-02-01 00:00:00

  • Allosteric pathways in nuclear receptors - Potential targets for drug design.

    abstract：:The nuclear receptor family of transcription factor proteins mediates endocrine function and plays critical roles in the development, physiology and pharmacology. Malfunctioning nuclear receptors are associated with several disease states. The functional activity of nuclear receptors is regulated by small molecular ho...

    journal_title：Pharmacology & therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/j.pharmthera.2017.10.014

    authors： Fernandez EJ

    更新日期：2018-03-01 00:00:00

  • Functional consequences of repeated organophosphate exposure: potential non-cholinergic mechanisms.

    abstract：:The class of chemicals known as the "organophosphates" (OPs) comprises many of the most common agricultural and commercial pesticides that are used worldwide as well as the highly toxic chemical warfare agents. The mechanism of the acute toxicity of OPs in both target and non-target organisms is primarily attributed t...

    journal_title：Pharmacology & therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/j.pharmthera.2012.03.001

    authors： Terry AV Jr

    更新日期：2012-06-01 00:00:00

  • Comparative effects of DHA and EPA on cell function.

    abstract：:Fish oil supplementation has been reported to be generally beneficial in autoimmune, inflammatory and cardiovascular disorders. Most researchers have attributed these beneficial effects to the high content of omega-3 fatty acids in fish oil (FO). The effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA...

    journal_title：Pharmacology & therapeutics

    pub_type： 杂志文章,评审

    doi：10.1016/j.pharmthera.2009.01.004

    authors： Gorjão R,Azevedo-Martins AK,Rodrigues HG,Abdulkader F,Arcisio-Miranda M,Procopio J,Curi R

    更新日期：2009-04-01 00:00:00